Spotlight on Naloxone Co-Prescribing | HHS.gov

Spotlight on Naloxone Co-Prescribing | HHS.gov

OASH Blog: Spotlight on Naolxone Co-Prescribing

As we recognize International Overdose Awareness Day, HHS is calling attention to the co-prescription of naloxone, the Food and Drug Administration (FDA)-approved medication that can save a person’s life when administered during an opioid overdose. Naloxone is available in three formulations – nasal spray, injectable, and auto-injector – and at least one form of naloxone is covered by most health insurance plans, including Medicaid and Medicare.

Learn More - https://www.hhs.gov/blog/2020/08/31/spotlight-naloxone-co-prescribing.html